Keryx announces positive interim results for mid stage trial drug for diabetic nephropathy treatmentMay 7th, 2005 Keryx Biopharmaceuticals (KERX) Announces Positive Interim Results From Phase 2 Clinical Study For KRX-101 (Sulodexide Gelcaps) For Treatment Of Diabetic Nephropathy. Around 40% of diabetic patients progress to diabetic nephropathy.
AIIMS / Indian Government Ideal For DCA Human Trial For Cancer TreatmentFebruary 5th, 2007 India is the ideal place to conduct human trial for the effectiveness of DCA ( dichloroacetate ) as anti-cancer drug. The government regulations for human trial aren't as stringest as USA, there are funds available for such studies and frankly you don't need much.
FDA OK's Cholesterol Drug Lipitor for DiabeticsSeptember 27th, 2005 Pfizer Inc. said U.S. regulators (FDA) have approved its cholesterol lowering drug Lipitor. Lipitor is used to reduce the risk of stroke and heart attack in diabetic patients.
Diabulimia: Forced Weight Loss by Diabetics Can KillJune 19th, 2007 Diabulimia is a new term used to describe an eating disorder that’s beginning to victimize type I diabetics. As with any other eating disorder teens are the most likely to develop it.
Ruboxistaurin (RBX) May Reduce Risk of Vision Loss in DiabeticsJuly 16th, 2005 A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association’s journal Diabetes brings hopeful news to the 18 million people in the United States -- and millions more worldwide -- with type 1 or type 2 diabetes. Initial results of the Phase III clinical trial demonstrated that 32 milligrams per day of ruboxistaurin (RBX) was well tolerated and may reduce the risk of moderate vision loss, especially in patients with diabetic macular edema.
Gene expression inhibitor drug made mice (STZ induced) diabetes resistantMarch 21st, 2005 Researchers from North Shore-Long Island Jewish Health System in Manhasset, N.Y. have identified a gene which expresses as a protein called macrophage migration inhibitory factor, or MIF.
Diabetes Treatment by Consuming TeaAugust 9th, 2005 Study conducted by researchers at the University of Scranton suggests that tea might prevent diabetes and its associated complications, including diabetic cataracts. Researchers led by Joe Vinson fed green and black tea to diabetic rats for three months and then monitored the chemical composition of the rats' blood and eye lenses.
Diovan (Blood Pressure Drug) Cuts Risk of Diabetes, Especially in High-Risk GroupMay 18th, 2005 Valsartan, commercially known as Diovan, a drug that controls blood pressure and reduces heart risk, also appears to protect against diabetes, especially in high-risk people, according to new research presented at the American Society of Hypertension's Twentieth Annual Scientific Meeting and Exposition (ASH 2005) by a University of Michigan physician who helped lead the study. The randomized trial involved 15,313 patients at 942 sites in 31 countries, of whom 9,995 did not have diabetes at the start of the study.
New Foot Surgery Method Helps in Neuropathy; May Prevent AmputationsMarch 13th, 2005 Diabetic foot care experts presenting at the American College of Foot and Ankle Surgeons Annual Scientific Conference said that foot and ankle surgeons are pioneering an approach to relieve pressure on nerves in diabetic feet that cause loos of sensation and foot ulcers. "The new surgical approach is to release the tarsal tunnel to decompress the nerve and allow it to regain circulation and regenerate," said DiNucci.
Indian's in High Risk Group for DiabetesApril 20th, 2005 Report from the 4th World Congress on Prevention of Diabetes and its Complications, organised by the World Health Organization and others.
Cheap Non-Patented Drug Kills Most CancersFebruary 3rd, 2007 Investigators at the University of Alberta have recently reported that the drug DCA is able to cause tumor regression in a number of human cancers growing in animals. The drug, dichloroacetate (DCA), is being used for years to treat rare metabolic disorders and is known to be relatively safe.
Research finds Statin simvastatin appears to prevent or reverse vascular injury in diabetic ratsApril 3rd, 2005 Since most patients with diabetes die from some vascular complication, Medical College of Georgia researchers set out to determine the effects of simvastatin on endothelial cell dysfunction, an early pivotal event in atherogenesis and a major cause of the microvascular complications in diabetics. The researchers found that in addition to lowering cholesterol levels, simvastatin also appeared to prevent or reverse vascular injury by vasoprotective means.
Breaking News: European Study Reports Halting of Progress of Type 1 Diabetes by Drug Anti-CD3 AntibodyJuly 17th, 2005 The European study of patients with Type I diabetes found that short-term treatment lowered insulin dependence by 12 percent and increased insulin-making capabilities for at least 18 months. "The results are very promising.
INGAP closer to cure diabetesMarch 18th, 2005 LOS ANGELES -- Researchers might be getting closer to finding a cure for diabetes. Researchers announced a new treatment and medicine, and the discovery of a gene that might play a role.
FDA Warns about Suicidal Thinking in Children and Adolescents on ADHD Drug - StratteraSeptember 29th, 2005 The Food and Drug Administration warned doctors on Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention deficit hyperactivity disorder (ADHD). Manufacturer Eli Lilly & Co.
Comment Below | 
Email this Article
Loading ...